Vimarsana
Biggest News Aggregation in the World

Pawan Jolly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pawan Jolly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pawan Jolly Today - Breaking & Trending Today

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies - Vimarsana News

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies

Not all SARS-CoV-2 infections are created equal. We have learned this through multiple virus waves are taking their toll on the world's population.

Wyss Institute Team Develops CRISPR, Antibody-Based SARS-CoV-2 Test - Vimarsana News

Wyss Institute Team Develops CRISPR, Antibody-Based SARS-CoV-2 Test

The electrochemical test detects both the presence of SARS-CoV-2 RNA as well as virus antibodies in saliva.

Source: 360dx.com
The iQ Group Global secures worldwide license for Harvard - Vimarsana News

The iQ Group Global secures worldwide license for Harvard

Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...

Harvard Wyss Institute's eRapid sensor technology licensed - Vimarsana News

Harvard Wyss Institute's eRapid sensor technology licensed

The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of...

Wyss Institute Licenses eRapid Sensor Technology to Antisoma Therapeutics - Vimarsana News

Wyss Institute Licenses eRapid Sensor Technology to Antisoma Therapeutics

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian biotech company The iQ Group Global Ltd. announced that the Institute's electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Ltd., a subsidiary of The iQ Group Global.